28 reports of this reaction
4.6% of all FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE reports
#3 most reported adverse reaction
DRUG EFFECT LESS THAN EXPECTED is the #3 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, manufactured by HyVee Inc. There are 28 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE to DRUG EFFECT LESS THAN EXPECTED. This represents approximately 4.6% of all 604 adverse event reports for this drug.
Patients taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE who experience drug effect less than expected should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG EFFECT LESS THAN EXPECTED is moderately reported among FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to drug effect less than expected, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE:
The following drugs have also been linked to drug effect less than expected in FDA adverse event reports:
DRUG EFFECT LESS THAN EXPECTED has been reported as an adverse event in 28 FDA reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG EFFECT LESS THAN EXPECTED accounts for approximately 4.6% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, making it one of the most commonly reported side effect.
If you experience drug effect less than expected while taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.